SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012866
Filing Date
2020-11-05
Accepted
2020-11-05 16:18:18
Documents
46
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20200930x10q.htm 10-Q 1101013
2 EX-31.1 nxtc-20200930ex311e0df7a.htm EX-31.1 12157
3 EX-31.2 nxtc-20200930ex312e34338.htm EX-31.2 11938
4 EX-32.1 nxtc-20200930ex321930387.htm EX-32.1 12254
  Complete submission text file 0001558370-20-012866.txt   4422956

Data Files

Seq Description Document Type Size
5 EX-101.INS nxtc-20200930.xml EX-101.INS 984205
6 EX-101.SCH nxtc-20200930.xsd EX-101.SCH 26316
7 EX-101.CAL nxtc-20200930_cal.xml EX-101.CAL 35804
8 EX-101.DEF nxtc-20200930_def.xml EX-101.DEF 103659
9 EX-101.LAB nxtc-20200930_lab.xml EX-101.LAB 303131
10 EX-101.PRE nxtc-20200930_pre.xml EX-101.PRE 202030
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 201290705
SIC: 2834 Pharmaceutical Preparations